We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies

Blog - Vaccines For Human Medicine

GlaxoSmithKline's Promising Outlook Amid Concerns
Merck Suspends Gardasil Shipments to China
Merck's Earnings Align with Expectations, Stock Declines on 2025 Forecast
Experts Predict Smaller Winter COVID Wave in U.S., Impacting Pfizer's Growth
AstraZeneca Abandons £450m Vaccine Facility Development in the UK
Sanofi's Strategic Share Buyback Amid Robust Q4 Performance
Moderna's Norovirus Vaccine Trial Advances Amid Surge in U.S. Cases
Moderna Secures an Additional $590 Million for Influenza Vaccine Development
Moderna Revises 2025 Sales Forecast Amid Weak Vaccine Demand
Moderna Shares Surge Amid H5N1 Vaccine Development
Novavax to Divest Czech Facility to Novo Nordisk for $200 Million
The Netherlands Sees a Major Decline in Vaccine Imports, Dropping to $712 Million in 2023
The Largest Import Markets for Vaccines: Key Statistics and Trends
Spain's Import of Vaccines Totals $7.3 Billion in 2023
Vaccines Imports in Canada Drop Significantly to $3.1 Billion in 2023
Global Vaccine Trade Gains Momentum, Surpassing $42B This Year
France, Ireland, and Belgium Are the Major Producers on the European Vaccines Market
Vaccine Market - Vaccine Exports From Belgium Seen Growing, Totaling $10,526M in 2014